Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|6|597-608

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.6, 2007-03, pp. : 597-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Therapeutic Potential of Inhibitors of Dipeptidyl Peptidase IV (DPP IV) and Related Proline-Specific Dipeptidyl Aminopeptidases

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 971-998

Bentham Science Publishers

Access to resources Recommend Favorite

Dipeptidyl peptidase-IV (DPP-IV) inhibitors enhance the paracrine antilipolytic effects of neuropeptide Y (NPY)

By  

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Docking Study of Novel Pyrrolidine Derivatives as Potential Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 4, 2015-05 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective

By  

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-01 ,pp. : 4013-4045

Bentham Science Publishers

Access to resources Recommend Favorite

Recent patents of dipeptidyl peptidase IV inhibitors

By Mendieta Laura   Tarrago Teresa   Giralt Ernest  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1693-1741

Informa Healthcare

Access to resources Recommend Favorite